rs17686437
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 8P and 10B. PVS1BP6_ModerateBS1BS2
The NM_020157.4(OTOR):c.2T>C(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0392 in 1,602,702 control chromosomes in the GnomAD database, including 1,395 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.032 ( 101 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1294 hom. )
Consequence
OTOR
NM_020157.4 start_lost
NM_020157.4 start_lost
Scores
7
8
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
OTOR (HGNC:8517): (otoraplin) This gene encodes a member of the melanoma-inhibiting activity gene family. The encoded protein is secreted via the Golgi apparatus and may function in cartilage development and maintenance. A frequent polymorphism in the translation start codon of this gene can abolish translation and may be associated with forms of deafness. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PVS1
?
Start lost variant, no new inframe start found.
BP6
?
Variant 20-16748403-T-C is Benign according to our data. Variant chr20-16748403-T-C is described in ClinVar as [Benign]. Clinvar id is 403282.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr20-16748403-T-C is described in Lovd as [Benign].
BS1
?
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0319 (4852/152252) while in subpopulation NFE AF= 0.0447 (3037/68012). AF 95% confidence interval is 0.0433. There are 101 homozygotes in gnomad4. There are 2409 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 101 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOR | NM_020157.4 | c.2T>C | p.Met1? | start_lost | 1/4 | ENST00000246081.3 | |
OTOR | XM_017027959.3 | c.2T>C | p.Met1? | start_lost | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOR | ENST00000246081.3 | c.2T>C | p.Met1? | start_lost | 1/4 | 1 | NM_020157.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0319 AC: 4854AN: 152134Hom.: 101 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
4854
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0348 AC: 8743AN: 251144Hom.: 191 AF XY: 0.0358 AC XY: 4857AN XY: 135716
GnomAD3 exomes
AF:
AC:
8743
AN:
251144
Hom.:
AF XY:
AC XY:
4857
AN XY:
135716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0399 AC: 57945AN: 1450450Hom.: 1294 Cov.: 28 AF XY: 0.0403 AC XY: 29086AN XY: 722410
GnomAD4 exome
AF:
AC:
57945
AN:
1450450
Hom.:
Cov.:
28
AF XY:
AC XY:
29086
AN XY:
722410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0319 AC: 4852AN: 152252Hom.: 101 Cov.: 32 AF XY: 0.0324 AC XY: 2409AN XY: 74454
GnomAD4 genome
?
AF:
AC:
4852
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
2409
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
164
ALSPAC
AF:
AC:
169
ESP6500AA
AF:
AC:
40
ESP6500EA
AF:
AC:
390
ExAC
?
AF:
AC:
4269
Asia WGS
AF:
AC:
41
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all):430/13006=3.3% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at